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Seizure Action Plans Do Not Reduce Health Care Utilization in 
Pediatric Epilepsy Patients
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Abstract
Management of pediatric epilepsy requires complex coordination of care. We hypothesized that an 
improved seizure management care plan would reduce healthcare utilization and improve 
outcomes. We conducted a cohort study with historical controls of 120 epilepsy patients before 
and after implementation of a “Seizure Action Plan.” We evaluated for differences in healthcare 
utilization including emergency department visits, hospitalizations, clinic visits, telephone calls, 
and the percentage of emergency department visits that resulted in hospitalization in patients who 
did or did not have a Seizure Action Plan. We found that there was no decrease in these measures 
of healthcare utilization, and in fact the number of follow-up clinic visits was increased in the 
group with Seizure Action Plans (4.2 versus 3.3, p 0.006). However, the study was underpowered 
to detect smaller differences. Our study suggests that pediatric epilepsy quality improvement 
measures may require alternative approaches to reduce healthcare utilization and improve 
outcomes.
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INTRODUCTION
Management of a child presenting with seizures is a complex process involving medical, 
social, and educational components. The process involves acute medical care, education of 
the family about medications, instructions for what to do if there is a seizure, 
implementation of potentially complicated medication regimens, and instructions for follow-
up. Families are often worried and upset when their child is admitted to the hospital, and 
education and instructions for treatment may not always be correctly understood. 
Management of epilepsy and other chronic conditions falls heavily on the patient/family and 
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their ability to adhere to medication regimens and understand their disease, including the 
need to understand potentially complicated plans in case of breakthrough seizures.1 
However, physicians may have unrealistic expectations that patients and families have 
adequate ability and resources to assume responsibility for management of their disease.2
Improved care for pediatric epilepsy patients, even in the absence of novel therapies, offers a 
potential for improving health outcomes and reducing healthcare utilization. Unexpected 
readmissions for seizures are the fourth most common reason for readmissions at children’s 
hospitals.3 Increased education of patients and families has been shown to improve 
understanding of epilepsy and appropriate anti-epileptic medication use.4 Certain strategies 
such as pre-hospital use of intranasal midazolam for a prolonged breakthrough seizure, have 
been demonstrated to reduce hospital admissions.5
Recent Cochrane reviews on patients with chronic medical conditions have concluded that 
patient/family-centered education programs can lead to improvements in ratings of health 
and symptoms, with reductions in hospital admissions.6, 7 For patients with epilepsy, studies 
have shown that educational programs significantly improved self-management behaviors.8 
However, there are contrary examples; for example, use of Asthma Action Plans did not 
decrease frequency of ED visits and hospitalizations.9
These findings led us to consider whether a detailed plan for children with epilepsy and their 
families might reduce health care utilization. We hypothesized that a written “Seizure 
Action Plan” (SAP) would minimize confusion about when to seek healthcare for seizures; 
reduce emergency department visits; and reduce in-patient admissions for seizure 
exacerbations. The SAP would include a list of current anti-epileptic medications and their 
dosages, instructions for use of rescue medications when necessary, instructions for break-
through seizures, and a specific follow-up plan. Our goal was to provide families and 
patients with clear instructions that would be readily available to them. We studied whether 
implementation of SAPs was associated with a change in the number of emergency 
department visits and subsequent admissions for seizures, and decreased need for families to 
contact us with questions.
METHODS
This study was approved by the Institutional Review Boards for the University of Utah and 
for Primary Children’s Hospital. We performed a cohort study with historical controls of 
patients with seizures before and after implementation of a seizure action plan (SAP). The 
study was performed at Primary Children’s Hospital (PCH), which provides primary 
pediatric care for the urban Wasatch Front region, and is also the sole tertiary children’s 
hospital within a 5 state catchment area for patients from Utah, Wyoming, Idaho, Nevada 
and Montana. Patients were identified from the Electronic Data Warehouse (EDW) 
maintained by PCH and Intermountain Healthcare, using a computerized search of 
International Classification of Disease, 9th Edition, Clinical Modification (ICD-9-CM, 
referred to subsequently as ICD-9) diagnosis codes, and confirmed by manual chart review. 
A total of 120 patients were analyzed; 60 consecutive patients prior to implementation of the 
SAP from January 1, 2007 through December 31, 2008; and 60 consecutive patients after 
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implementation of the SAP from January 1, 2010 through December 31, 2011. Each patient 
was followed for outcomes for 18 months after the index presentation. There was no overlap 
of patients in the SAP and no SAP groups.
Patients were included in the study if they were admitted to PCH with a seizure during the 
study time period; and had a discharge diagnosis of seizure or epilepsy (ICD-9 345.xx or 
780.xx). Diagnosis was also confirmed at the time of chart review. The timeframe dates for 
controls (no SAP, “nSAP”) group was 1/2007–12/2008; and was 1/2010–12/2011 for the 
SAP group. Patients were excluded from the study for febrile seizures, seizures provoked by 
illness or trauma, non-epileptogenic seizures, patients admitted electively for video EEG 
monitoring, patients with epilepsy admitted for diagnostic evaluation solely, and patients 
who underwent epilepsy surgery during the study period.
The SAP was designed to provide families and patients with information that might be 
forgotten or difficult to remember, and that would be helpful in a situation of breakthrough 
seizures or for determining timing of follow-up (Figure 1). The template for the SAP, which 
included name and date of birth, was automatically generated by the electronic medical 
record system, and patient-specific details were filled out by the clinician. SAPs were 
discussed either one-on-one with a family, or sometimes in a larger group of medical 
personnel, at the time of discharge. SAP introduction to families was not scripted; and 
discussion of SAPs at follow-up clinic visits was left to the discretion of the individual 
clinician. For the analyses included in this manuscript only SAPs used for hospitalized 
patients were included. SAPs for patients who presented initially in the outpatient setting 
were not included in order to maintain a potentially less heterogenous population for 
analysis. Discussion about the SAP in follow-up was left to the discretion of the clinician.
Data collected included demographic data including age, gender, ethnicity, and diagnosis; 
and outcomes data including the number of emergency department (ED) visits, number of 
hospitalizations for seizures, number of pediatric neurology follow-up clinic visits, number 
of phone calls to the pediatric neurology offices which was recorded as the number of 
“Message Logs” entered into the electronic medical record (message logs are the nurse-
entered record of phone calls), length of index hospitalization and number of anti-epileptic 
drugs (AEDs) at discharge. Outcomes data were collected for each patient for the 18-month 
period following the index admission. Data was managed using REDCap (Research 
Electronic Data Capture) hosted at the University of Utah.10
Statistical Analysis
De-identified patient data was entered into the REDCap database, including demographic 
information, number of AEDs, number of emergency department visits, number of 
neurology clinic follow-up visits, number of phone calls to the pediatric neurology offices, 
and number of hospitalizations for seizures. Comparison was made of outcomes from 
patients who did not receive a SAP, to patients who did receive one. Descriptive statistics 
were used to characterize the study cohort. The two-proportion z-test was used to calculate 
p-values of demographic data. Wilcoxon Rank-Sum tests were used to compare outcomes; p 
values were two-sided. We used SAS University Edition (SAS Institute, Inc., Cary, NC) for 
analyses.
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RESULTS
The total study cohort of 120 patients included 60 control patients from 2007–2008, prior to 
seizure action plan (SAP) implementation (the no seizure action plan group, “nSAP”), and 
60 patients from 2010–2011, after SAP implementation (“SAP” group) (Table 1). In the 
SAP cohort there were more males (p 0.029) and a higher percentage of children who were 
on 4 or more AEDs (p 0.028). Otherwise demographics of the two cohorts were similar, 
including age, ethnicity, length of hospitalization, and discharge diagnosis.
The SAP included a list of current AEDs and dosages, instructions for use of rescue 
medications when necessary, instructions for break-through seizures, and a specific follow-
up plan (Figure 1). To determine whether use of a SAP reduced health care utilization we 
measured several outcomes, including number of ED visits, number of hospital admissions, 
number of pediatric neurology clinic visits, number of phone calls to the pediatric neurology 
offices (Figure 2), and the percentage of ED visits that resulted in hospitalization (Figure 3). 
There were no statistically significant differences in these outcomes between the SAP and 
nSAP groups (Table 2), except that the number of follow-up clinic visits was increased in 
the group with Seizure Action Plans (4.2 versus 3.3, p 0.006).
Because of the difference in baseline demographics between the SAP and nSAP groups, 
with more SAP patients on 4 or more AEDs, we performed a subgroup analysis on the 59 
nSAP patients compared to the 53 SAP patients who were on fewer than 4 AEDs (shown in 
Table 2). In this subgroup analysis there also were no significant differences identified 
between the SAP and nSAP groups. Of note, the number of males compared to females, 
which showed a statistically significant difference in the original analysis, was not 
significant in the subgroup analysis.
DISCUSSION
We found that a SAP had no effect in decreasing healthcare utilization in pediatric epilepsy 
patients. We did not find any statistically significant decreases in emergency department 
utilization, hospital admissions, or telephone messages between the two groups. In fact, we 
observed that the number of follow-up clinic visits was increased in the group with SAPs 
(4.2 versus 3.3, p 0.006). Nor did we find a difference in the percentage of ED visits that 
resulted in hospitalization. Our study is one of the first that we are aware of to attempt to 
improve pediatric epilepsy patient care by reducing healthcare utilization.14
We compared different outcome measures in patients with epilepsy who did or did not have 
a SAP. In the comparison between groups there was no decrease in utilization in patients 
who had a SAP. For example, the number of emergency department visits in the no SAP 
group was 2.5 visits, compared to 3 in the SAP group. Since we found a statistically 
significant higher percentage of SAP patients who were taking four or more anti-epileptic 
medications (p 0.028), we also performed a subgroup analysis of the two groups for those 
patients on fewer than four anti-epileptic medications. Even for the subgroup analysis there 
was no decrease in utilization by the SAP group. For example, clinic visits were 3.4 in the 
no SAP group and 4 in the SAP group.
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Pediatric epilepsy patients have significant medical costs,11 and there is significant variation 
across institutions in how care for these patients is delivered.12 Some studies have shown 
that increased education can improve understanding of epilepsy 4 and that lay-education 
programs can improve health and reduce hospitalizations. 2, 3 Interestingly, however, our 
findings mirror a Joint Commission study of Asthma Action Plans, in which there was the 
unexpected finding that implementation of Asthma Action Plans did not decrease frequency 
of ED visits and hospitalizations.9 Other studies of pediatric asthma patients have found that 
adolescent patients or patients with public insurance had higher readmission rates.13 Thus, 
there may be unexpected and/or unrecognized clinical and social factors to uncover in order 
to design methods to reduce epilepsy healthcare utilization.
Limitations to this study include that is was conducted retrospectively; and that the patient 
cohorts were collected during different time epochs. There was a potential bias in that 
patients in the control (nSAP) group were on fewer overall medications, suggesting that the 
patients in the nSAP group had less severe epilepsy. However, even when we performed a 
sub-group analysis consisting of only patients on 3 or fewer AEDs, our results still showed 
no difference in outcomes between SAP and nSAP groups. Further, a Fisher’s exact test 
comparing the proportion of patients on three or more AEDs versus two or fewer, in the 
SAP and nSAP, shows no statistical difference (two-tailed p=0.25).
It is possible that we have not identified the appropriate outcome measures, and that ED 
visits and hospitalizations are not the best reflections of SAP efficacy. Also, our cohort of 60 
patients and a follow-up of 18 months may not have been sufficient to detect more subtle 
differences, and our post-hoc power analysis revealed a power of only 3–7%. Further, 
examining hospital admissions, if we assumed an 80% power and significance level of 5%, 
the effect size is only 0.14 (Cohen’s d), indicating near complete overlap of the SAP and 
nSAP groups. Thus, our work provides important direction for future research, suggesting 
that significantly larger patient cohorts will be necessary.
This study did not address whether there was improved education as a result of 
implementation of the SAP. While assumed to be true, simply providing the SAP document 
may not have resulted in “adequate” education to affect outcomes. SAPs were not discussed 
in a standardized fashion when introduced to families; and discussion of SAPs at follow-up 
clinic visits was left to the discretion of the individual clinician. This variability could 
potentially obscure the utility of SAPs.
In conclusion, we found no significant change in healthcare utilization following the 
implementation of the SAP. Potential future studies to reduce pediatric epilepsy healthcare 
utilization could include a more standardized provision of the SAP; changes in the format 
(for example, larger fonts or uses of bright colors) of the SAP; or inclusion of on-line links 
to information on epilepsy. For example, we have developed a “Medical Home Portal” that 
provides on-line information for families on commonly diagnosed neurological conditions 
including epilepsy.15 Another approach for a revised SAP might include an explicit flow 
diagram, instructing parents to call the on-call provider for any seizure. While this would 
likely result in an increase in phone calls, we could determine if this intervention might 
reduce emergency department and admission rates. Other SAPs have also been developed, 
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for example by the Epilepsy Foundation16 and by many school districts; but their efficacy 
has not been evaluated. Future studies could also examine family perception of complexity 
of disease management, and on perceived stress associated with the diagnosis of epilepsy 
and management. Studies such as these can lead towards identification of factors necessary 
to improve pediatric epilepsy patient health.
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FIGURE 1. 
A sample Seizure Action Plan to be provided to a patient/family upon discharge from the 
hospital.
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FIGURE 2. 
Number of ED visits, hospital admissions, neurology clinic follow-up visits and telephone 
messages (“message logs”) before (No SAP) and after (SAP) implementation of a Seizure 
Action Plan, each group compared over 18 months. There were no statistically significant 
differences in outcomes between the groups. Box plots (25th and 75th percentiles); center 
line, median; whiskers, 1.5 interquartile range.
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FIGURE 3. 
Percentage of ED visits that result in hospital admission before (No SAP) and after (SAP) 
implementation of a Seizure Action Plan. There was no statistical difference between the 
groups, p= 0.99. Error bars, binomial proportion confidence interval (95% confidence 
interval).
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TABLE 1
Patient characteristics and demographics. nSAP = prior to implementation of Seizure Action Plan (2007–
2008); SAP = after implementation of Seizure Action Plan (2010–2011). N=60 for each group. First number 
listed is absolute number followed by percentage (out of 60) in parentheses. Highlighted values indicate those 
that are statistically significant. “Discharge Diagnosis” is based on the primary ICD-9 code used. AED, anti-
epileptic drug.
Characteristic nSAP (%) SAP (%) p value
Age (years)
  0–2 17 (28%) 16 (26%) 0.84
  3–18 43 (72%) 44 (74%)
Gender (male) 25 (42%) 37 (62%) 0.029
Race/Ethnicity
  Non-Hispanic White 38 (63%) 47 (78%) 0.25*
  Non-Hispanic Black 0 (0%) 0 (0%)
  Hispanic/Latino 8 (13%) 7 (12%)
  Asian 1 (2%) 0 (0%)
  Pacific Islander 2 (3%) 1 (2%)
  Middle Eastern 0 (0%) 1 (2%)
  Other/Unknown 11 (18%) 4 (7%)
Insurance (Medicaid) 21 (36%) 18 (30%) 0.70
Hospital Length of Stay (days) 0.67**
    0–1 21 (35%) 19 (32%)
    2–3 24 (40%) 25 (42%)
    4–6 9 (15%) 13 (22%)
    >7 6 (10%) 3 (5%)
Discharge Diagnosis (from initial hospitalization) 0.28^
  Intractable Epilepsy 25 (42%) 30 (50%)
  Grand Mal Status 19 (32%) 21 (35%)
  Other Convulsions 16 (27%) 9 (15%)
Number of AEDs at Discharge 0^^
  0 5 (8%) 3 (5%)
  1 25 (42%) 22 (37%)
  2 20 (33%) 16 (27%)
  3 9 (15%) 12 (20%)
  4 or more 1 (2%) 7 (12%)
*7×2 chi-square test.
**Wilcoxon signed-rank test.
^3×2 chi-square test.
^^7×2 chi-square test.
J Child Neurol. Author manuscript; available in PMC 2017 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Roundy et al. Page 12
Ta
bl
e 
2
O
ut
co
m
es
 in
 S
A
P 
an
d 
nS
A
P 
gr
ou
ps
. N
um
be
rs
 (m
ea
n; 
me
dia
n i
n p
are
nth
ese
s) 
(as
 di
sp
lay
ed
 in
 Fi
gu
res
 2 
an
d 3
) f
or 
he
alt
hc
are
 ut
iliz
ati
on
 be
for
e a
nd
 af
ter
 
im
pl
em
en
ta
tio
n 
of
 se
iz
ur
e 
ac
tio
n 
pl
an
 a
re
 p
ro
vi
de
d.
 S
ub
gr
ou
p 
an
al
ys
is 
on
ly
 in
cl
ud
ed
 p
at
ie
nt
s o
n 
3 
or
 fe
w
er
 a
nt
i-e
pi
le
pt
ic
 d
ru
gs
 (A
ED
s).
 O
utc
om
es 
an
d 
co
rr
es
po
nd
in
g 
p 
v
al
ue
 sh
ow
n.
O
ut
co
m
es
In
iti
al
 A
na
ly
sis
Su
bg
ro
up
 A
na
ly
sis
(p
ati
en
ts 
on
 <4
 A
ED
s)
n
SA
P
n
=
60
SA
P
n
=
60
p-
va
lu
e
n
SA
P
n
=
59
SA
P
n
=
53
p-
va
lu
e
ED
 V
isi
ts
2.
5(2
)
3.
0(3
)
0.
17
2.
5(2
)
3.
0(3
)
0.
16
A
dm
iss
io
ns
1.
8(1
)
2.
0(2
)
0.
37
1.
8(2
)
1.
9(2
)
0.
65
F/
up
 v
isi
ts
3.
3(3
)
4.
2(4
)
0.
00
6
3.
4(3
)
4.
0(4
)
0.
02
9
M
es
sa
ge
 L
og
s
11
.7
(7)
14
.1
(10
)
0.
10
11
.9
(12
)
13
.3
(13
)
0.
30
%
 E
D
 V
isi
ts
 th
at
 re
su
lte
d 
in
 h
os
pi
ta
liz
at
io
n
81
.7
%
81
.9
%
0.
99
82
.0
%
75
.7
%
0.
43
J Child Neurol. Author manuscript; available in PMC 2017 March 01.
